PMID 11233822
Back Klausen, MK, Jensen, ME, Mller, M, et al (6 Sept 2022) 'Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial', JCI Insight, 7/19, e159863
It can be used for: Adults: obese adults (BMI 30 kg/m2 or greater) overweight adults (BMI 27 kg/m2 or greater) who also have weight-related medical problems e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia
This includes custom dosing plans, unlimited check-ins, and continuous medical oversight
The majority of events were reported as diabetic retinopathy (4%, 2.7%, and 2.7%, respectively) and non-proliferative retinopathy (0.7%, 0%, and 0%, respectively)
Researchers should store reconstituted GHK-Cu according to the stability guidance and monitor the solutions appearance, since changes in color or clarity can indicate degradation that would alter the effective GHK-Cu dosage delivered